Rockwell Medical (NASDAQ: RMTI)
Rockwell Medical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Rockwell Medical Company Info
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.
News & Analysis
Rockwell Medical Tops Q2 EPS View
Why Rockwell Medical Stock Is Tanking Today
The price of Rockwell Medical's latest stock offering wasn't right for investors.
Why Kratos Defense & Security Solutions, Bitauto Holdings, and Rockwell Medical Slumped Today
Find out what caused these stocks to miss out on a good market day.
3 Ways Rockwell Medical Inc. Could Turn Things Around
The pharma continues to struggle. Here's how things could get better.
Rockwell Medical Stock Upgraded: What You Need to Know
There's a potential for a huge profit here -- but not many investors are buying it.
Will Rockwell Medical Inc. Sink or Swim?
The company's success depends heavily on its ability to get its iron replacement drug Triferic on a more profitable course.
Why Rockwell Medical, Inc. Shares Are Crashing Today
Poor sales for its recently launched Triceric have investors heading for the exit.
3 Predictions for Rockwell Medical Inc. in 2016
Will new iron-replacement drug Triferic live up to its potential in the new year?
Valuation
Earnings Transcripts
Rockwell Medical RMTI Q2 2025 Earnings Transcript
None
Rockwell Medical (RMTI) Q2 2019 Earnings Call Transcript
RMTI earnings call for the period ending June 30, 2019.
Rockwell Medical (RMTI) Q1 2019 Earnings Call Transcript
RMTI earnings call for the period ending March 31, 2019.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.